FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Levetiracetam Extended-Release Oral Tablets, USP
Status: Resolved
»Duration of Shortage: 05/28/2019 - 03/16/2021
»Therapeutic Categories: Neurology

Expand all

Apotex Corp. (Revised 03/16/2021)

Company Contact Information:
800-706-5575

Presentation
  • Levetiracetam Extended-Release Tablets 500 mg (60 ct. bottle)(NDC 60505-3280-06)
  • Levetiracetam Extended-Release Tablets 750 mg (60 ct. bottle)(NDC 60505-3517-06)
Note:
  • N/A

Lupin (Revised 03/16/2021)

Company Contact Information:
866-587-4617

Presentation
  • 500mg 60 count bottle (NDC 68180-117-07)
  • 750mg 60 count bottle (NDC 68180-118-07)
Note:
  • N/A

Solco Healthcare US, LLC (Revised 03/16/2021)

Company Contact Information:
866-931-9829

Presentation
  • Levetiracetam ER Tablets, 500mg, 60’s (NDC 43547-0345-06)
  • Levetiracetam ER Tablets, 500mg, 500’s (NDC 43547-0345-50)
  • Levetiracetam ER Tablets, 750mg, 60’s (NDC 43547-0346-06)
  • Levetiracetam ER Tablets, 750mg, 500’s (NDC 43547-0346-50)
Note:
  • Long-term backorder for all skus. No estimated release date at this time.

Sun Pharmaceutical Industries Inc. (Revised 03/16/2021)

Company Contact Information:
800-818-4555

Presentation
  • 500mg tablet 60 count bottle (NDC 4733557386)
  • 750mg tablet 60 count bottle (NDC 4733557686)
Note:
  • N/A

UCB Inc. (Revised 03/16/2021)

Company Contact Information:
844-599-2273

Presentation
  • 500mg extended-release (NDC 50474-598-66)
  • 750mg extended-release (NDC 50474-599-66)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English